UK Interdisciplinary Breast Cancer Symposium – ICC in Birmingham 22-23rd January 2024

Dear Colleagues

The next UK Interdisciplinary Breast Cancer Symposium is due to take place at the ICC in Birmingham 22-23rd January 2024.

This is the 4th Meeting of UKIBCS, and the previous meetings have been very successful bringing together oncologists, surgeons, radiologists, pathologists, scientists and others involved in breast cancer research and management. Further details of the programme and how to register can be found on:

www.ukibcs.org

The programme has been put together to address wide-ranging issues in breast cancer research and management with renowned speakers from the UK, Europe and USA.

Abstracts can be submitted for poster presentations and prizes will be given for the best abstracts.

It would be great if as many pharmacists as can attend as this is the major multidisciplinary breast cancer meeting in the UK. Please forward to your colleagues in your hospital

 

Professor Andreas Makris

Chairman of UKIBCS

 

Consultant Clinical Oncologist
Mount Vernon Cancer Centre
Northwood
Middlesex HA6 2RN
UK

Email: [email protected]

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article